Teva to Cut 7,000 Jobs After Disappointing Quarter Results
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
DEF 14A
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results | AlphaStreet
TEVA REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva and OncoGenex announce top-line survival results of Phase III SYNERGY trial evaluating custirsen in combination with first-line docetaxel and prednisone - Drug Target Review
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
Teva Pharmaceutical loses another CEO, leaving investors to guess what's next | Mint
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Can Teva Pharmaceutical's Q4 results bring positive surprise? | Seeking Alpha
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Analysts see upside in Teva share price - גלובס
Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease - Huntington's Disease News
Teva Reports First Quarter 2021 Financial Results | Business Wire
